Chronic lung disease · preterm neonates after extubation
Nasal intermittent positive pressure ventilation (NIPPV) showed no clear difference in chronic lung disease (oxygen supplementation at 36 weeks) compared with nasal continuous positive airway pressure (NCPAP) (moderate certainty).
1 finding from 1 review
Chronic lung disease · )
Nasal intermittent positive pressure ventilation (NIPPV) may leads to lower chronic lung disease compared with nasal continuous positive airway pressure (NCPAP) (by population) (low certainty).
1 finding from 1 review
3a. Chronic lung disease at 36 weeks' postmenstrual age – doxapram compared to no treatment for the prevention of reintubation · prevention of reintubation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bronchopulmonary dysplasia/chronic lung disease · prevention of reintubation
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Chronic lung disease · the fetus/neonate/infant
Summary of findings table ‐ Repeat dose(s) of prenatal corticosteroid showed no clear difference in A8: Chronic lung disease – all fetuses randomised compared with single course (high certainty).
1 finding from 1 review
Chronic lung disease · preterm infants
It is very uncertain whether lower changes chronic lung disease (36 weeks' corrected age) compared with higher oxygen concentrations titrated to target oxygen saturations… (very low certainty).
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
It is very uncertain whether late (seven days or more following birth) higher changes chronic lung disease compared with lower sodium intake (very low certainty).
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
1 finding from 1 review
Chronic lung disease · preterm or low birth weight infants
1 finding from 1 review
Chronic lung disease · women at risk of preterm birth
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic lung disease · women at risk of preterm birth
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Chronic lung disease · women at risk of preterm birth
It is very uncertain whether betamethasone 12‐hourly changes chronic lung disease compared with 24‐hourly dosing – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
Chronic lung disease · women at risk of preterm birth
Dexamethasone showed no clear difference in chronic lung disease compared with betamethasone – fetal/neonatal outcomes (moderate certainty).
1 finding from 1 review
Chronic lung disease · prevention of sepsis and necrotizing enterocolitis in preterm infants
It is very uncertain whether lactoferrin supplementation with enteral feeds in combination with… changes chronic lung disease compared with placebo (very low certainty).
1 finding from 1 review
Chronic lung disease · preventing respiratory failure in preterm infants
1 finding from 1 review
Chronic lung disease · preterm infants
Very early treatment showed no clear difference in chronic lung disease compared with expectant management (low certainty).
1 finding from 1 review
Chronic lung disease · preterm infants
Early treatment showed no clear difference in chronic lung disease compared with expectant management (moderate certainty).
1 finding from 1 review
Chronic lung disease · preterm infants (< 37 weeks GA) at risk of chronic lung disease
Summary of findings table ‐ Salbutamol showed no clear difference in chronic lung disease at 28 days compared with placebo (low certainty).
1 finding from 1 review
Bronchopulmonary dysplasia/chronic lung disease · preterm infants resuscitated by PPV at birth
Use of initial sustained inflation showed no clear difference in chronic lung disease ‒any grade compared with standard inflations (moderate certainty).
1 finding from 1 review
Chronic lung disease · preterm infants with respiratory distress for initial respiratory support
nHFV may leads to lower chronic lung disease compared with nIPPV used (low certainty).
1 finding from 1 review